{
    "nctId": "NCT05533320",
    "briefTitle": "Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastatic Breast Cancer",
    "officialTitle": "Evaluation Of Benefits of The Portable Scalp Cooling System (PSCS) in Metastatic Breast Cancer Patients on Taxane-Based Chemotherapy",
    "overallStatus": "WITHDRAWN",
    "conditions": "Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Success in hair preservation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Documented informed consent of the participant\n* Age: \\>= 18 years\n* Eastern Cooperative Oncology Group (ECOG) =\\< 2\n* Ability to read and understand English or Spanish for questionnaires\n* Documented diagnosis of metastatic breast cancer with at least a 6 month life expectancy\n* A planned course of taxane based chemotherapy in the metastatic setting, including paclitaxel, docetaxel or abraxane\n* At least 6 months from the last chemotherapy causing hair loss with complete recovery of hair\n* Willing to be contacted for brief annual assessments for five years\n* Women of childbearing potential (WOCBP): negative urine pregnancy test\n* Agreement by females of childbearing potential to use an effective method of birth control or abstain from heterosexual activity for the course of the study\n\n  * Childbearing potential defined as not being surgically sterilized (men and women) or have not been free from menses for \\> 1 year (women only)\n\nExclusion Criteria:\n\n* Autoimmune disease affecting hair; e.g. alopecia areata, systemic lupus with associated hair loss\n* A history of whole brain radiation with persistent hair thinning or alopecia, or concurrent whole brain radiation therapy\n* Exposure to other investigational agents, drugs, device or procedure that may cause hair loss\n* Patients with female pattern baldness resembling picture I-3 or higher on the Savin scale\n* Any cutaneous scalp metastases\n* Clinically significant liver dysfunction considered significant as determined by treating physician that would limit the patient's ability to administer the scalp cooling device\n* Clinically significant renal dysfunction considered significant as determined by treating physician that would limit the patient's ability to administer the scalp cooling device\n* A history of persistent grade 2 (or higher) alopecia induced by prior chemotherapeutic regimens\n* Evidence of untreated or poorly controlled hyper or hypothyroidism\n* American Society of Anesthesiologist Class \\>= 3\n* Any other condition that would, in the Investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures\n* Pregnant or breastfeeding\n* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}